Dogwood Therapeutics Inc expected to post a loss of $1.90 a share - Earnings Preview

Dogwood Therapeutics

04/08/2025 14:23

Dogwood Therapeutics Inc DWTX.OQ DWTX.O is expected to  show no change in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Dogwood Therapeutics Inc is for a loss of $1.90 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Dogwood Therapeutics Inc is $11.00, about 55.9% above its last closing price of $4.85

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-2.50
-2.37
-4.19
Missed
-76.4
Dec. 31 2025
-1.49
-1.41
-5.87
Missed
-314.8
Sep. 30 2024
-1.10
-1.18
-2.05
Missed
-74.2​
Jun. 30 2024
-1.56
-1.58
-1.25
Beat
21
​​Mar. 31 2024
-1.00
-1.00
-1.75
Missed
-75
Dec. 31 2023
-2.24
-2.25
-1.50
Beat
33.3​
Sep. 30 2023
-2.37
-2.37
-1.50
Beat
36.8
Jun. 30 2023
-1.75
-1.75
-2.00
Missed
-14.3

This summary was machine generated August 4 at 13:23 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)